The FDA has accepted a revised application for Vyglxia, a drug previously rejected by the agency. An expert panel will review the findings, with a new decision expected in the first quarter of next year. #FDA #Vyglxia #Biohaven
New verdict on Vyglxia expected in first quarter of next year
Source: BioPharma Dive
realfeedapp.com